Location History:
- Jiangsu, CN (2023)
- Suzhou, CN (2021 - 2024)
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Inventor Yunfei Huo
Introduction
Yunfei Huo is a notable inventor based in Suzhou, China. He has made significant contributions to the field of medical technology, particularly in the area of coronary artery analysis. With a total of 4 patents to his name, Huo's work is paving the way for advancements in non-invasive cardiac assessments.
Latest Patents
Huo's latest patents include a "Method for calculating coronary artery fractional flow reserve on basis of myocardial blood flow and CT images." This innovative method involves determining myocardial volume by extracting myocardial images, accurately segmenting coronary arteries, and generating a grid model for calculation. It also includes determining myocardial blood flow in a resting state and calculating total flow during maximum hyperemia. Another significant patent is the "Method for calculating index of microcirculatory resistance based on myocardial blood flow and CT image." This method similarly focuses on myocardial volume extraction and flow calculations, providing critical insights into coronary artery health.
Career Highlights
Yunfei Huo is currently employed at Suzhou Rainmed Medical Technology Co., Ltd. His work at this company emphasizes the importance of innovative medical solutions that enhance patient care and diagnostic accuracy. Huo's expertise in medical imaging and flow analysis has positioned him as a key figure in the development of advanced cardiac assessment tools.
Collaborations
Huo collaborates with talented professionals in his field, including Guangzhi Liu and Xingyun Wu. These collaborations foster a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Yunfei Huo's contributions to medical technology through his patents and collaborative efforts are instrumental in advancing cardiac health assessments. His innovative methods are set to improve the accuracy and efficiency of coronary artery evaluations, ultimately benefiting patient outcomes.